Stress Echocardiography by the ABCDE Protocol ln the Assessment of Prognosis of Stable Coronary Heart Disease

Aim. To assess the role of clinical indicators and parameters of stress echocardiography performed according to an extended protocol as predictors for the occurrence of a composite cardiovascular endpoint (CCVEP) in IHD.

Material and methods. The study included 186 patients (60.2% men, mean age 60.6±9.9 years) with an established (n=73; 39.2%) and suspected (60.8%) diagnosis of IHD. Stress EchoCG with adenosine triphosphate (38.2%), transesophageal pacing (15.1%), dobutamine (2.6%), and bicycle ergometry on a recumbent ergometer (44.1%) was performed. The stress EchoCG protocol included assessment of regional wall motion abnormalities (WMA), B-lines, LV contractile reserve (CTR), coronary reserve (CR), and heart rate reserve. The median follow-up period was 13 [9; 20] months. The composite CCVEP included death from cardiovascular diseases and their complications, acute coronary syndrome, and revascularization and was defined at the first of these events. Statistical analysis was performed with the Statistica 16.0 and SPSS Statistics 23.0 software packages. Differences were considered statistically significant at p<0.05.

Results. Invasive or noninvasive coronary angiography was performed in 90.3% of patients; obstructive coronary disease (stenosis ≥50%) was detected in 67.9% of cases. During the follow-up period, 58 (31.2%) patients had cardiovascular complications. The risk of developing CCVEP was associated with the pretest probability (PTP) of ischemic heart disease (odds ratio, OR, 1.05; 95% confidence interval, CI, 1.02-1.08), dyslipidemia (DLP) (OR 0.40; 95% CI 0.20-0.82), carotid atherosclerosis (OR 0.39; 95% CI 0.18-0.86), LV ejection fraction (OR 0.96; 95% CI 0.93-0.99), appearance at peak stress of new significant (2 LV segments or more) regional WMAs (OR 0.32; 95% CI 0.18-6.55), decreased LV CTR (OR 0.46; 95% CI 0.27-0.79) and CR (OR 0.33; 95% CI 0.18-0.61); p<0.05 for all. In a multivariate analysis with Cox regression, the model with clinical indicators included PTP of IHD (OR 1.04; 95% CI 1.01-1.07; p=0.01) and DLP (OR 0.14; 95% CI 0.02-1.01; p=0.05) as predictors. The model with stress EchoCG parameters included the appearance of new significant WMAs (OR 0.33, 95% CI 0.16-0.65; p=0.001) and reduced <2.0 CR (OR 0.44; 95% CI 0.24-0.82; p=0.01). A comparative analysis of Kaplan-Meier curves confirmed statistically significant differences in the dynamics of the CCVEP occurrence depending on the absence or presence of hemodynamically significant WMAs and/or reduced CR during stress EchoCG (p<0.01).

Conclusion. Reduced LV CR and WMA during stress EchoCG in patients with suspected or confirmed IHD are significant independent predictors for the CCVEP occurrence. Among clinical indicators, PTP of IHD and DLP are of the greatest importance for prognosis.

1. Karpov Yu.A., Kukharchuk V.V., Lyakishev A.A., Lupanov V.P., Panchenko E.P., Komarov A.L. et al. Diagnosis and treatment of chronic ischemic heart disease. Cardiology bulletin. 2015;10(3):3–33.

2. Barbarash O.L., Karpov Yu.A., Kashtalap V.V., Boshchenko A.A., Ruda M.Ya., Akchurin R.S. et al. 2020 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020;25(11):201–50. DOI: 10.15829/1560-4071-2020-4076

3. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2020;41(3):407–77. DOI: 10.1093/eurheartj/ehz425

4. Marwick TH, Case C, Vasey C, Allen S, Short L, Thomas JD. Prediction of Mortality by Exercise Echocardiography: A Strategy for Combination With the Duke Treadmill Score. Circulation. 2001;103(21):2566–71. DOI: 10.1161/01.CIR.103.21.2566

5. Sicari R, Pasanisi E, Venneri L, Landi P, Cortigiani L, Picano E. Stress echo results predict mortality: a large-scale multicenter prospective international study. Journal of the American College of Cardiology. 2003;41(4):589–95. DOI: 10.1016/S0735-1097(02)02863-2

6. Chung G, Krishnamani R, Senior R. Prognostic value of normal stress echocardiogram in patients with suspected coronary artery disease – A British general hospital experience. International Journal of Cardiology. 2004;94(2–3):181–6. DOI: 10.1016/j.ijcard.2003.03.020

7. Picano E, Zagatina A, Wierzbowska-Drabik K, Borguezan Daros C, D’Andrea A, Ciampi Q. Sustainability and Versatility of the ABCDE Protocol for Stress Echocardiography. Journal of Clinical Medicine. 2020;9(10):3184. DOI: 10.3390/jcm9103184

8. Pellikka PA, Arruda-Olson A, Chaudhry FA, Chen MH, Marshall JE, Porter TR et al. Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease: From the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2020;33(1):1-41.e8. DOI: 10.1016/j.echo.2019.07.001

9. Cortigiani L, Huqi A, Ciampi Q, Bombardini T, Bovenzi F, Picano E. Integration of Wall Motion, Coronary Flow Velocity, and Left Ventricular Contractile Reserve in a Single Test: Prognostic Value of Vasodilator Stress Echocardiography in Patients with Diabetes. Journal of the American Society of Echocardiography. 2018;31(6):692–701. DOI: 10.1016/j.echo.2017.11.019

10. Ciampi Q, Zagatina A, Cortigiani L, Wierzbowska-Drabik K, Kasprzak JD, Haberka M et al. Prognostic value of stress echocardiography assessed by the ABCDE protocol. European Heart Journal. 2021;42(37):3869–78. DOI: 10.1093/eurheartj/ehab493

11. Scali MC, Zagatina A, Ciampi Q, Cortigiani L, D’Andrea A, Daros CB et al. Lung Ultrasound and Pulmonary Congestion During Stress Echocardiography. JACC: Cardiovascular Imaging. 2020;13(10):2085–95. DOI: 10.1016/j.jcmg.2020.04.020

12. Ciampi Q, Zagatina A, Cortigiani L, Gaibazzi N, Borguezan Daros C, Zhuravskaya N et al. Functional, Anatomical, and Prognostic Correlates of Coronary Flow Velocity Reserve During Stress Echocardiography. Journal of the American College of Cardiology. 2019;74(18):2278–91. DOI: 10.1016/j.jacc.2019.08.1046

13. Zagatina A, Zhuravskaya N, Shmatov D, Ciampi Q, Carpeggiani C, Picano E. Exercise stress echocardiography with ABCDE protocol in unexplained dyspnoea. The International Journal of Cardiovascular Imaging. 2020;36(5):823–31. DOI: 10.1007/s10554-020-01789-6

14. Kelshiker MA, Seligman H, Howard JP, Rahman H, Foley M, Nowbar AN et al. Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis. European Heart Journal. 2022;43(16):1582–93. DOI: 10.1093/eurheartj/ehab775

15. Cortigiani L, Rigo F, Gherardi S, Bovenzi F, Picano E, Sicari R. Implication of the Continuous Prognostic Spectrum of Doppler Echocardiographic Derived Coronary Flow Reserve on Left Anterior Descending Artery. The American Journal of Cardiology. 2010;105(2):158–62. DOI: 10.1016/j.amjcard.2009.08.669

16. Boshchenko A.A., Vrublevsky A.V., Karpov R.S. Coronary Flow Reserve in the Left Anterior and Posterior Descending Arteries as an Additional Option to Dipyridamole Stress Echocardiography for Detection of Stenosis. Kardiologiia. 2016;56(4):54–63. DOI: 10.18565/cardio.2016.4.54-63

17. Chaowalit N, McCully RB, Callahan MJ, Mookadam F, Bailey KR, Pellikka PA. Outcomes after normal dobutamine stress echocardiography and predictors of adverse events: long-term follow-up of 3014 patients. European Heart Journal. 2006;27(24):3039–44. DOI: 10.1093/eurheartj/ehl393

18. Cortigiani L, Carpeggiani C, Landi P, Raciti M, Bovenzi F, Picano E. Usefulness of Blunted Heart Rate Reserve as an Imaging-Independent Prognostic Predictor During Dipyridamole Stress Echocardiography. The American Journal of Cardiology. 2019;124(6):972–7. DOI: 10.1016/j.amjcard.2019.06.017

19. Cortigiani L, Azzolina D, Ciampi Q, Lorenzoni G, Gaibazzi N, Rigo F et al. Machine Learning Algorithms for Prediction of Survival by Stress Echocardiography in Chronic Coronary Syndromes. Journal of Personalized Medicine. 2022;12(9):1523–35. DOI: 10.3390/jpm12091523

20. Picano E, Ciampi Q, Arbucci R, Cortigiani L, Zagatina A, Celutkiene J et al. Stress Echo 2030: the new ABCDE protocol defining the future of cardiac imaging. European Heart Journal Supplements. 2023;25(Suppl C):C63–7. DOI: 10.1093/eurheartjsupp/suad008